HERON THERAPEUTICS, INC. /DE/ HRTX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1987-08-26
HERON THERAPEUTICS, INC. /DE/ statistics & valuation
Market cap$81.4M
P / S0.5×
P / B5.7×
Net margin-13.0%
Return on equity-140.9%
FCF margin-18.0%
Return on capital-1.6%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 73.3% | 73.2% | 48.8% | 49.0% | — | — | — | — | — | — |
| Operating margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% | -257.4% | -144.3% | -237.4% | -632.4% | -13363.2% |
| Net margin | -13.0% | -9.4% | -87.0% | -169.1% | -255.6% | -256.4% | -140.3% | -230.8% | -641.9% | -13537.4% |
| FCF margin | -18.0% | -16.8% | -47.5% | -138.1% | -239.0% | -216.2% | -90.2% | -259.4% | -561.8% | -10729.6% |
| Return on assets | -7.9% | -5.8% | -49.7% | -72.5% | -72.2% | -64.3% | -39.9% | -38.7% | -84.3% | -256.6% |
| Return on equity | -140.9% | 40.4% | 325.4% | -1341.2% | -284.5% | -96.1% | -50.7% | -48.3% | -150.6% | 814.8% |
| Current ratio | 2.48 | 2.29 | 2.37 | 2.49 | 3.58 | 3.07 | 4.95 | 4.86 | 2.21 | 1.60 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.